Skip to main content

Closed

PLRX: Pliant Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-61.5%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage-67.7×

Current ratio16.89×

Pliant Therapeutics, Inc.

PLRXNASDAQ Global Select·USD·Closed

Pliant Therapeutics, Inc.

PLRXNASDAQ·USD·Closed

$1.04

−1.89%

$1.04

−$0.02 (1.89%)

52W Range

0thpctl

Volume

0.63×avg

Mkt Cap

64.40MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.63×avg

Market Cap

64.40MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings